Cross Country Healthcare drops amid news of FTC meeting next week
FTC Meeting Impact on Cross Country Healthcare: Cross Country Healthcare's stock fell by 5.7% following the FTC's announcement of a closed-door meeting, raising investor concerns about the review of Aya Healthcare's $615 million acquisition of the company.
Concerns Over Acquisition Documents: Reports indicate that the FTC has found "troubling documents" related to the acquisition, leading to a second request for information from Cross Country regarding the deal.
Trade with 70% Backtested Accuracy
Analyst Views on CCRN
About CCRN
About the author
Cross Country Healthcare to Hold Q4 2025 Earnings Call
- Earnings Call Scheduled: Cross Country Healthcare will hold a conference call on March 4, 2026, at 5:00 PM ET to discuss its Q4 and full-year 2025 financial results, with the earnings press release set to be distributed after market close, aiming to keep investors informed of the latest financial performance.
- Live Webcast and Replay: The call will be webcast live on the company's website, with participants able to dial in at 800-369-2163 (U.S.) or 773-756-4715 (non-U.S.), and a replay will be available from March 4 to March 18, ensuring that investors who cannot attend live can still access critical information.
- Intellify® Platform Overview: Cross Country Healthcare leverages its Intellify® platform, a cloud-based workforce management and vendor management system, to help healthcare organizations optimize their labor ecosystem, improve resource utilization, and reduce complexity, thereby maintaining a competitive edge in the healthcare industry.
- Company Background and Vision: As a technology-driven company with nearly 40 years of healthcare labor expertise, Cross Country Healthcare aims to help health systems achieve sustainable labor optimization through AI-powered digital platforms and advisory services, enhancing service quality and operational efficiency.
Cross Country Healthcare CEO John Martins Resigns, Names Kevin Clark as Successor
Leadership Change: John Martins has resigned as President and CEO of Cross Country Healthcare, effective December 14, with Kevin Clark appointed as his successor.
Experience of New CEO: Kevin Clark, who co-founded the company and has nearly 40 years of experience in the healthcare staffing industry, will also continue as Chairman of the Board.
Market Reaction: Following the announcement, Cross Country Healthcare's stock rose by 4.83% to $8.90 in pre-market trading on the Nasdaq.
Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.
Crude Oil Rises More Than 1%; Kroger Stock Declines Following Q3 Earnings Report
U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Nasdaq Composite rising 0.2%, while the Dow fell slightly by 0.04%. Kroger's stock dropped 6% after reporting mixed quarterly results, despite beating earnings expectations.
Sector Movements: Industrials sector shares increased by 0.7%, while consumer staples stocks fell by 1.2%. Notable gainers included Polyrizon Ltd. (up 92%) and UiPath Inc. (up 22%), while Genesco Inc. saw a significant drop of 30%.
Commodity Prices: Oil prices rose by 1.5% to $59.85, while gold increased by 0.2%. In contrast, silver and copper prices fell by 2% and 0.5%, respectively.
Global Market Trends: European shares were generally higher, with the eurozone's STOXX 600 up 0.45%. Asian markets also closed mostly higher, led by Japan's Nikkei, which gained 2.33%.
US Stocks Rise; Dollar General's Shares Surge Following Positive Earnings Report
U.S. Stock Market Performance: U.S. stocks saw a slight increase, with the Dow Jones up 0.1%, NASDAQ rising 0.01%, and S&P 500 gaining 0.1% on Thursday. Financial shares rose by 0.4%, while health care stocks fell by 0.6%.
Dollar General's Strong Earnings: Dollar General's shares surged over 7% after reporting better-than-expected third-quarter earnings of $1.28 per share and raising its FY25 guidance above estimates.
Notable Stock Movements: Polyrizon Ltd. shares skyrocketed 134% following positive preclinical test results, while Genesco Inc. shares plummeted 28% after disappointing financial results and lowered guidance.
Global Market Trends: European shares rose, with the eurozone's STOXX 600 up 0.5%, and Asian markets mostly closed higher, led by Japan's Nikkei gaining 2.33%. U.S. initial jobless claims decreased by 27,000 to 191,000.
Cross Country Healthcare Ends Merger with Aya Holdings; Aya to Pay $20 Million Penalty
Merger Termination: Cross Country Healthcare (CCRN) has terminated its merger agreement with Aya Holdings due to the inability to extend the deal beyond the December 3, 2025, deadline, resulting in a $20 million termination fee owed by Aya to Cross Country.
Regulatory Delays: The merger faced delays from an FTC Hart-Scott-Rodino review, exacerbated by a historic government shutdown, which pushed the review's end date past the merger's termination date.
Market Impact: Following the announcement of the merger's termination, CCRN shares dropped by 19.6%.
Company Performance: Cross Country Healthcare has missed financial estimates and canceled its earnings call while suspending guidance due to the pending transaction.
Cross Country Healthcare Reports Financial Results for Third Quarter 2025
Financial Performance Overview: Cross Country Healthcare reported a revenue of $250.1 million for Q3 2025, a 21% decrease year-over-year, with a net loss of $4.8 million and a diluted EPS of $(0.15). Adjusted EBITDA was $6.5 million, reflecting a 37% decline compared to the previous year.
Business Segment Highlights: The Nurse and Allied Staffing segment generated $202 million in revenue, down 24% year-over-year, while Physician Staffing revenue decreased by 4% to $48.1 million. The company experienced a positive cash flow from operations of $20.1 million for the quarter.
Merger Update: Cross Country Healthcare is in the process of merging with Aya Healthcare, with the merger agreement set to close by December 3, 2025, pending regulatory approvals. The merger's timeline has been affected by a government shutdown impacting the FTC's review process.
Operational Efficiency: The company has successfully reduced SG&A expenses and maintained a healthy balance sheet with $99 million in cash and no debt. They have also focused on enhancing their proprietary technology platforms while securing over $400 million in contract value across Managed Service Program clients.
Cross Country Healthcare to Hold Q4 2025 Earnings Call
- Earnings Call Scheduled: Cross Country Healthcare will hold a conference call on March 4, 2026, at 5:00 PM ET to discuss its Q4 and full-year 2025 financial results, with the earnings press release set to be distributed after market close, aiming to keep investors informed of the latest financial performance.
- Live Webcast and Replay: The call will be webcast live on the company's website, with participants able to dial in at 800-369-2163 (U.S.) or 773-756-4715 (non-U.S.), and a replay will be available from March 4 to March 18, ensuring that investors who cannot attend live can still access critical information.
- Intellify® Platform Overview: Cross Country Healthcare leverages its Intellify® platform, a cloud-based workforce management and vendor management system, to help healthcare organizations optimize their labor ecosystem, improve resource utilization, and reduce complexity, thereby maintaining a competitive edge in the healthcare industry.
- Company Background and Vision: As a technology-driven company with nearly 40 years of healthcare labor expertise, Cross Country Healthcare aims to help health systems achieve sustainable labor optimization through AI-powered digital platforms and advisory services, enhancing service quality and operational efficiency.
Cross Country Healthcare CEO John Martins Resigns, Names Kevin Clark as Successor
Leadership Change: John Martins has resigned as President and CEO of Cross Country Healthcare, effective December 14, with Kevin Clark appointed as his successor.
Experience of New CEO: Kevin Clark, who co-founded the company and has nearly 40 years of experience in the healthcare staffing industry, will also continue as Chairman of the Board.
Market Reaction: Following the announcement, Cross Country Healthcare's stock rose by 4.83% to $8.90 in pre-market trading on the Nasdaq.
Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.
Crude Oil Rises More Than 1%; Kroger Stock Declines Following Q3 Earnings Report
U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Nasdaq Composite rising 0.2%, while the Dow fell slightly by 0.04%. Kroger's stock dropped 6% after reporting mixed quarterly results, despite beating earnings expectations.
Sector Movements: Industrials sector shares increased by 0.7%, while consumer staples stocks fell by 1.2%. Notable gainers included Polyrizon Ltd. (up 92%) and UiPath Inc. (up 22%), while Genesco Inc. saw a significant drop of 30%.
Commodity Prices: Oil prices rose by 1.5% to $59.85, while gold increased by 0.2%. In contrast, silver and copper prices fell by 2% and 0.5%, respectively.
Global Market Trends: European shares were generally higher, with the eurozone's STOXX 600 up 0.45%. Asian markets also closed mostly higher, led by Japan's Nikkei, which gained 2.33%.
US Stocks Rise; Dollar General's Shares Surge Following Positive Earnings Report
U.S. Stock Market Performance: U.S. stocks saw a slight increase, with the Dow Jones up 0.1%, NASDAQ rising 0.01%, and S&P 500 gaining 0.1% on Thursday. Financial shares rose by 0.4%, while health care stocks fell by 0.6%.
Dollar General's Strong Earnings: Dollar General's shares surged over 7% after reporting better-than-expected third-quarter earnings of $1.28 per share and raising its FY25 guidance above estimates.
Notable Stock Movements: Polyrizon Ltd. shares skyrocketed 134% following positive preclinical test results, while Genesco Inc. shares plummeted 28% after disappointing financial results and lowered guidance.
Global Market Trends: European shares rose, with the eurozone's STOXX 600 up 0.5%, and Asian markets mostly closed higher, led by Japan's Nikkei gaining 2.33%. U.S. initial jobless claims decreased by 27,000 to 191,000.
Cross Country Healthcare Ends Merger with Aya Holdings; Aya to Pay $20 Million Penalty
Merger Termination: Cross Country Healthcare (CCRN) has terminated its merger agreement with Aya Holdings due to the inability to extend the deal beyond the December 3, 2025, deadline, resulting in a $20 million termination fee owed by Aya to Cross Country.
Regulatory Delays: The merger faced delays from an FTC Hart-Scott-Rodino review, exacerbated by a historic government shutdown, which pushed the review's end date past the merger's termination date.
Market Impact: Following the announcement of the merger's termination, CCRN shares dropped by 19.6%.
Company Performance: Cross Country Healthcare has missed financial estimates and canceled its earnings call while suspending guidance due to the pending transaction.
Cross Country Healthcare Reports Financial Results for Third Quarter 2025
Financial Performance Overview: Cross Country Healthcare reported a revenue of $250.1 million for Q3 2025, a 21% decrease year-over-year, with a net loss of $4.8 million and a diluted EPS of $(0.15). Adjusted EBITDA was $6.5 million, reflecting a 37% decline compared to the previous year.
Business Segment Highlights: The Nurse and Allied Staffing segment generated $202 million in revenue, down 24% year-over-year, while Physician Staffing revenue decreased by 4% to $48.1 million. The company experienced a positive cash flow from operations of $20.1 million for the quarter.
Merger Update: Cross Country Healthcare is in the process of merging with Aya Healthcare, with the merger agreement set to close by December 3, 2025, pending regulatory approvals. The merger's timeline has been affected by a government shutdown impacting the FTC's review process.
Operational Efficiency: The company has successfully reduced SG&A expenses and maintained a healthy balance sheet with $99 million in cash and no debt. They have also focused on enhancing their proprietary technology platforms while securing over $400 million in contract value across Managed Service Program clients.
